MedTrace Logo

Cohorte Nationale VIH-2

NCT04658329 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1185

Last updated 2020-12-08

No results posted yet for this study

Summary

The HIV2 study is an open cohort of prospective, multicentric, national observation. The main objective is to study HIV-2 infection in adult patients followed in France.

Conditions

  • HIV-2 Infection

Interventions

DRUG

Antiretroviral

Study the response to antiretroviral treatment (clinical, immuno-virological) and contribute to the identification of the antiretroviral strategies and combinations most suited to the particularities of the infection.

Sponsors & Collaborators

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • François Dabis, Pr, MD · ANRS, Emerging Infectious Diseases

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-01-01
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04658329 on ClinicalTrials.gov